890332002: Cedazuridine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Cytidine deaminase inhibitor\Cedazuridine

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Cedazuridine

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Cedazuridine
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine nucleoside\Cedazuridine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4012235012 Cedazuridine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4012236013 Cedazuridine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cedazuridine	Is a	Pyrimidine nucleoside	true	Inferred relationship	Some
Cedazuridine	Is a	Cytidine deaminase inhibitor	true	Inferred relationship	Some
Cedazuridine	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cytidine deaminase inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing cedazuridine and decitabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cedazuridine	Inferred relationship	Some	2
Cedazuridine and decitabine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cedazuridine	Inferred relationship	Some	2
Cedazuridine- and decitabine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cedazuridine	Inferred relationship	Some	2
Product containing only cedazuridine and decitabine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cedazuridine	Inferred relationship	Some	2
Cedazuridine 100 mg and decitabine 35 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Cedazuridine	Inferred relationship	Some	2
Cedazuridine 100 mg and decitabine 35 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cedazuridine	Inferred relationship	Some	2

Reference Sets